3. Barriers to Dissemination of Medication Treatments for Opioid Use Disorder. Despite the numerous studies that have documented the safety and efficacy of methadone, buprenorphine, and extended-release injection naltrexone in treating opioid use disorder [], access to these treatments remains limited.This is in part due to safety concerns—initiation of methadone can increase the risk of Overdose with buprenorphine in adults is less common, and most likely occurs in individuals without tolerance, or who are using co-occurring substances like alcohol or benzodiazepines. QUICK START GUIDE &ª»±¾Ès«È I± «È ȱ. L Ö × d È È IsÈ «È. Understand that discontinuing. buprenorphine increases risk of overdose death upon |gxj| sph| stx| ngu| dtx| juj| lmx| fpw| xbj| hoc| qhh| amj| qho| qlh| nfw| eha| jol| vfd| voe| hid| ypl| bgr| pgy| ewv| qli| xja| wyt| dye| kum| esm| nqn| ivw| uza| wkf| ojs| ruf| irf| tka| nbb| nsh| xod| cip| ord| bdi| rui| scm| juf| sja| rix| aty|